Enhancing Nutrition Therapy with Glucose Monitoring for Prediabetes
Background and Objectives
Prediabetes increases the risk of serious health issues like type 2 diabetes and heart disease. Early detection and lifestyle education are essential to prevent these complications. This study explored how real-time feedback from continuous glucose monitoring (CGM) can improve individualized nutrition therapy (INT) for overweight or obese individuals with prediabetes.
Methods
Participants (average age: 55 years; average BMI: 31.1 kg/m²) were divided into two groups: a treatment group (15 participants) and a control group (15 participants). Both groups received INT and CGM, but the control group did not see their CGM data until the study ended. Participants were monitored for 30 days, visiting the lab every 10 days for CGM updates and dietary advice.
Results
The treatment group experienced:
- More time in the target blood glucose range (p = 0.02)
- Lower average blood glucose levels (p < 0.05)
- Improved glucose management indicators (p = 0.02)
- Less variation in blood glucose (p = 0.01)
- Reduced time spent in high blood glucose ranges (p = 0.04)
These improvements were not seen in the control group.
Conclusions
Integrating CGM feedback with INT significantly improved blood glucose management for overweight or obese individuals with prediabetes.
Clinical Trial Importance
Clinical trials are vital for developing effective treatments. Our AI platform, DocSym, combines ICD-11 standards, clinical protocols, and research into a user-friendly resource for healthcare providers.
Streamlining Healthcare
In today’s healthcare landscape, efficiency is key. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, simplifying patient care management and expanding digital services.
Improving Patient Outcomes
By leveraging AI, clinics can optimize workflows, enhance patient outcomes, and reduce reliance on paper processes. Discover more about our solutions at aidevmd.com.
